COVID-19 test has filed for creditor protection after pausing shipments of the product due to a recently identified issue with the system.Spartan Bioscience Inc.
says the problem is not a safety issue.The Ottawa-based company says it’s seeking protection from creditors while it restructures its operations and refines the test’s performance.